Medical marijuana company Aurora Cannabis Inc (CVE:ACB) reported a new disclosure procedure for its third-party quality control assessment, which it says will ascertain customers of the purity of its offerings. This update comes amid growing issues over recalls of contaminated pot offered by Health Canada-approved manufacturers. Every product offered by company now is offered with a certificate of analysis given by cannabis testing lab Anandia Labs.
Aurora Cannabis, which is based in Cremona, and has offices in Vancouver, stated that the certificates will represent that its products have been assessed with high accuracy for potency and successfully completed Anandia’s rigorous testing processes for the presence of pollutants. The certificates are available on the company’s mobile app and its website for ordering medical pot.
Anandia Labs stated that it tests for 51 pesticides as well as plant growth regulators and other contaminants such as heavy metals and bacteria. Terry Booth, the CEO of Aurora Cannabis, reported that it is central that users have confidence in the safety of offerings they buy, and in the integrity of the medicinal cannabis system. Booth said that his firm’s move will raise the standard for the entire sector, and provide a model for other firms to follow.
Aurora’s initiative follows a series of pesticide-linked recalls at Canadian medicinal marijuana producers Mettrum and Organigram and a January recall by company itself, which sold selected Organigram products to its clients.
Since those recall instances, Health Canada has got 13 reports of negative reactions as of March 6, 2017. Health Canada spokesman André Gagnon reported that that data is not, on their own, evidence of a specific substance instigating a reaction.
Earlier this year, New Brunswick-based Organigram issued an intentional recall of offerings sold last year after they were seen to have low levels of the pesticides bifenazate and myclobutanil. Both these pesticides aren’t approved by Health Canada for application on cannabis plants.
DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of financialstrend.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: